|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 | |
网站主页 >> 化工产品目录 >> 伊马替尼盐酸盐>> 市场分析报告 |
伊马替尼盐酸盐市场分析报告 |
|
Gastric Cancer Drugs Market by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2023-2028 ... difficulty swallowing food. Doxorubicin hydrochloride, sunitinib, mitomycin, fluorouracil, imatinib, and docetaxel are ... . This includes doxorubicin hydrochloride, sunitinib, docetaxel, mitomycin, fluorouracil, imatinib, and trastuzumab. According ... Gastric Cancer Drugs Market Report by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2025-2033 ... difficulty swallowing food. Doxorubicin hydrochloride, sunitinib, mitomycin, fluorouracil, imatinib, and docetaxel are ... . This includes doxorubicin hydrochloride, sunitinib, docetaxel, mitomycin, fluorouracil, imatinib, and trastuzumab. According ... Global Nilotinib Hydrochloride Market Research Report 2025(Status and Outlook) ... growth characteristic of CML. Nilotinib Hydrochloride is typically prescribed for patients ... therapy with imatinib, another TKI. It is formulated as a hydrochloride salt to enhance ... landscape of the Global Nilotinib Hydrochloride Market, this report ... Global Gastric Cancer Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 ... seven types: doxorubicin hydrochloride, sunitinib, docetaxel, mitomycin, fluorouracil, imatinib, and trastuzumab. The ... by Type, covers Doxorubicin Hydrochloride Sunitinib Docetaxel Mitomycin Fluorouracil Imatinib Trastuzumab Market Segment ... Global Gastric Cancer Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 ... market status of Hospitals (Doxorubicin Hydrochloride, Sunitinib), Clinics (Doxorubicin Hydrochloride, Sunitinib), and key ... segment by Type Doxorubicin Hydrochloride Sunitinib Docetaxel Mitomycin Fluorouracil Imatinib Trastuzumab Market segment ... Global Cancer Generics Market Forecast to 2022 Within the pharmaceutical industry, the oncology market is growing at a rapid pace owing to the rising incidences of cancer. In 2015, 15.2 Million new cancer cases were registered across the globe. This number is forecasted to increase to a value of 19.3 ... Global Gastric Cancer Drugs Market Growth 2024-2030 ... data, market segmentation by Type (e.g., Doxorubicin Hydrochloride, Sunitinib), and regional breakdowns. Market ... . Segmentation by type Doxorubicin Hydrochloride Sunitinib Docetaxel Mitomycin Fluorouracil Imatinib Trastuzumab Segmentation by application ... Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2019 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review ... 2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ... ethyl, IFX-1, Iloprost , ILT101, Imatinib, IMM-101, IMU-838 ... -PAD, Povidone-iodine, Prasugrel Hydrochloride, Prazosin, Prednisolone, Previfenon, Probiorinse ... , Progesterone, Prolongin, Propranolol Hydrochloride, Proxalutamide, PSC-04, PTC299, PUL ... COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update ... ethyl, IFX-1, Iloprost , ILT101, Imatinib, IMM-101, IMU-838 ... -PAD, Povidone-iodine, Prasugrel Hydrochloride, Prazosin, Prednisolone, Previfenon, Probiorinse ... , Progesterone, Prolongin, Propranolol Hydrochloride, Proxalutamide, PSC-04, PTC299, PUL ... Ewing Sarcoma - Pipeline Review, 2019 ... of drugs: Cosmegen (Dactinomycin) Doxorubicin Hydrochloride Eribulin Mesylate Gleevec (Imatinib Mesylate) Halaven (Eribulin ... Mesylate) Trabectedin Votrient (Pazopanib Hydrochloride) Yondelis (Trabectedin ... Global Nilotinib Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023 Nilotinib in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine ... inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. Scope ... Global Tasigna Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023 Nilotinib in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine ... inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. Scope ... Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Tasigna Drug Market 2018, Forecast to 2023 Nilotinib in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine ... inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. Scope ... Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Nilotinib Drug Market 2018, Forecast to 2023 Nilotinib in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine ... inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. Scope ... Global Gastric Cancer Drugs Market Research Report 2025(Status and Outlook) ... Segmentation (by Type) Doxorubicin Hydrochloride Sunitinib Docetaxel Mitomycin Fluorouracil Imatinib Trastuzumab Market Segmentation ... (COVID Version) Global Gastric Cancer Drugs Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use ... Market by Type Doxorubicin Hydrochloride Sunitinib Docetaxel Mitomycin Fluorouracil Imatinib Trastuzumab Market by Application ... Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Retinopathy - Drugs In Development, 2022 ... 2023-2028 Global and Regional Gastric Cancer Drugs Industry Status and Prospects Professional Market Research Report Standard Version ... HealthCare By Types: Doxorubicin Hydrochloride Sunitinib Docetaxel Mitomycin Fluorouracil Imatinib Trastuzumab By Applications: Hospitals ... Global Gastric Cancer Drugs Market Report (2019-2030) ... , by product types: Doxorubicin Hydrochloride Sunitinib Docetaxel Mitomycin Fluorouracil Imatinib Trastuzumab Market segmentation ... |